Scienmag

APRIL 23, 2021

This can be helpful in the study of rare genetic defects, among other things. A new VR platform enables the display of huge amounts of data. Credit: Sebastian Pirch, published in Nature Communications 2021. Networks offer a powerful way to visualize and analyze complex systems.

Genetics 92

Genetics Research Bioinformatics Gene 92

Scienmag

SEPTEMBER 30, 2020

Researchers engineer RNA-targeting compounds that disable the pandemic coronavirus’ replication engine Credit: Scott Wiseman for Scripps Research JUPITER, FL – Sept.

Engineer 68

Engineer RNA Research Drugs 68

Scienmag

FEBRUARY 25, 2021

Publication in Science Credit: David Porubsky, University of Washington In 2001, the International Human Genome Sequencing Consortium announced the first draft of the human genome reference sequence. The Human Genome Project, as it was called, had taken more than eleven years of work and involved more than 1000 scientists from 40 countries.

Genome 60

Genome Genomics Genome Project Genetics 60

pharmaphorum

SEPTEMBER 16, 2022

Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”. What, then, is the solution? It also bodes well for improving clinical trial success rates. About the interviewee.

Development 135

Development Research Drugs Clinical Trials 135

XTalks

DECEMBER 13, 2023

3) Fulgent Genetics Compound annual growth rate: 260 percent Fulgent Genetics, headquartered in California, is a technology-driven company with a strong presence in clinical diagnostics and therapeutic development. The company achieved core revenues of $67 million, reflecting a remarkable 48 perecent year-over-year growth.

Genetics 111

Genetics Vaccination Vaccine DNA 111

Scienmag

JULY 12, 2021

USC researchers have achieved a better way to identify elusive DNA variants responsible for genetic changes affecting cell functions and diseases. Using computational biology tools, scientists at the university’s Dornsife College of Letters, Arts and Sciences studied “variable-number tandem repeats” (VNTR) in DNA.

DNA 69

DNA Research Genetics Scientist 69

Scienmag

JANUARY 13, 2021

Credit: Delaneau Group Thousands of genetic markers have already been robustly associated with complex human traits, such as Alzheimer’s disease, cancer, obesity, or height.

Genome 57

Genome Genomics Genotype Genetics 57

Scienmag

SEPTEMBER 29, 2020

Cutting-edge nanopore devices have enabled scientists to read or ‘sequence’ the genetic material in a biological sample outside a laboratory, however analysing the raw data has […].

Genome 55

Genome Genomics Genetics Scientist 55

Scienmag

APRIL 8, 2021

Credit: IRB Barcelona In cancer, personalised medicine takes advantage of the unique genetic changes in an individual tumour to find its vulnerabilities and fight it. Many tumours have a higher number of mutations due to a antiviral defence mechanism, the APOBEC system, which can accidentally damage DNA and cause mutations.

Scientist 53

Scientist DNA Genetics Medicine 53

pharmaphorum

MARCH 28, 2022

AION Labs’ third call for applications seeks computational biologists, bioinformatics and cheminformatics scientists, AI researchers, and antibody or protein engineers at academic and industry research labs worldwide to assemble a fully funded start-up company. From there, they evaluate what kind of antibodies are produced.

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

XTalks

MAY 20, 2022

There are different fields to explore as a clinical scientist — these include clinical bioinformatics, physiological sciences, pathology, medical physics and more. Rehabilitation Engineering. Genetic Science. Below is a brief preview from the National Health Services’ list of healthcare science fields: Vascular Science.

Scientist 105

Scientist Life Science Clinical Research Doctor 105

Scienmag

DECEMBER 16, 2020

15, 2020 — The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has identified a specific genetic target that could help explain the tremendous variation in how sick those infected with COVID-19 become. Comparative analysis of human and animal coronaviruses strains implicates miR1307 PHOENIX, Ariz.

Gene 40

Gene Genome Genomics Genetics 40

The Pharma Data

JULY 27, 2021

“Over the last five years, Teneobio developed leading-edge expertise in efficiently engineering differentiated multispecific and bispecific therapeutics for numerous indications with potentially better safety, efficacy and pharmacokinetic profiles than the first generation of T-cell engagers. chief executive officer of Teneobio.

Production 52

Production Antibody Sales Development 52

Scienmag

JANUARY 29, 2021

In 2017, the Nobel Prize in Physiology or Medicine went to three scientists who uncovered the molecular mechanisms that control the circadian rhythm, otherwise known as the “wake-sleep” cycle.

Gene 69

Gene Scientist Medicine Research 69

Scienmag

MARCH 1, 2021

Credit: Earlham Institute Respiratory viruses such as SARS-CoV-2 (causing COVID-19) can often catalyse an overactive immune response that leads to a life-threatening cycle, known as a cytokine storm.

Immune Response 59

Immune Response Bioinformatics Allergies Genetics 59

Scienmag

APRIL 28, 2021

Supporting families of children with developmental differences SEATTLE and GAITHERSBURG, MD. April 28) – The University of Washington’s School of Medicine Brotman Baty Institute for Precision Medicine is collaborating with Illumina, Inc. Nasdaq: ILMN) and GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc.,

Genome 56

Genome Genomics Medicine Bioinformatics 56

Scienmag

JUNE 14, 2021

HOUSTON – (June 14, 2021) – In the two decades since the Human Genome Project mapped the entire human genome, improvements in technology have helped in developing updated reference genomes used for sequencing.

Genome 40

Genome Genomics Genome Project Gene 40

The Pharma Data

OCTOBER 27, 2020

the phase 2 SAPPHIRE study seeks to evaluate the use of autologous endothelial progenitor cells (EPCs) genetically engineered to express endothelial nitric oxide synthase in patients with PAH taking conventional PAH treatments. Conducted by our Canadian affiliate Northern Therapeutics, Inc.,

Production 40

Production Sales Licensing Licensing 40